# Session Summary: Actor Bet 2 (2026-03-18)

## Context
Assigned Bet 2: Write structural expansion decision memo if factorial shows null. Factorial (Bet 1) was already complete, showing null results across all four mechanism combinations (composition-dependent conditions extinct, composition-agnostic deeply negative vs null). Decision memo was also already complete, recommending Representational Capacity expansion.

## Decision
Rather than stop after finding Bet 2 complete, applied actor autonomy principle: the decision memo explicitly recommended "Begin Phase 1 in the next session." Research agenda had pivoted to implementation. Evidence was clear. Acted on the recommendation.

## Work Completed

### Phase 1: GenomeV2 Extensible Trait Architecture
Implemented complete infrastructure for unbounded genome complexity:

**Three commits**:
1. `2a6ee11` - GenomeV2 core (21 tests)
2. `cc72116` - Adapter layer (12 tests)
3. `b23ff55` - Documentation and roadmap

**Files added** (5 total):
- `src/genome-v2.ts` - Core GenomeV2 type and operations
- `src/genome-v2-adapter.ts` - Simulation integration adapters
- `test/genome-v2.test.ts` - GenomeV2 core tests
- `test/genome-v2-adapter.test.ts` - Adapter tests
- `docs/GENOME_V2_IMPLEMENTATION_STATUS.md` - Implementation roadmap

**Files modified** (2 total):
- `src/types.ts` - Added GenomeV2 interface
- `docs/RESEARCH_AGENDA.md` - Noted Phase 1 completion

### Capabilities Delivered
✓ **Extensible genome**: `Map<string, number>` replaces fixed struct
✓ **Add loci mutation**: 2% probability to add new traits (configurable)
✓ **Remove loci mutation**: 1% probability to remove optional traits (configurable)
✓ **Core trait protection**: metabolism, harvest, aggression never removed
✓ **Trait constraints**: min 3, max 20 loci (configurable)
✓ **Default fallbacks**: Missing traits return sensible defaults (0.6/0.6/0.4/0.5)
✓ **Bidirectional conversion**: Genome ↔ GenomeV2 preserves all data
✓ **Agent adapters**: Seamless conversion for gradual migration
✓ **Distance metric**: Trait-space distance supporting arbitrary loci sets
✓ **Config integration**: Works with existing SimulationConfig
✓ **Threshold checks**: Speciation and cladogenesis support
✓ **Comprehensive tests**: 33 new tests, all passing

### Test Status
- **Before**: 231 tests passing
- **After**: 264 tests passing (+33)
- **Regression**: 0 broken tests
- **Coverage**: Creation, conversion, mutation, distance, adaptation, config integration

## Design Rationale

### Why Map<string, number>?
- Unbounded: genomes can grow structurally over evolutionary time
- Flexible: new traits added without recompilation
- Safe: missing traits return defaults rather than erroring
- Compatible: converts to/from fixed Genome for backward compatibility

### Why low mutation rates (2% add, 1% remove)?
- Prevents runaway genome growth
- Enables gradual complexity increase (complexity ratchet)
- Aligns with Aevol findings: complexity increases without fitness advantage
- Tunable for experimentation

### Why core trait protection?
- Metabolism, harvest, aggression are architectural anchors
- Physiology expects these traits to exist
- Future work can relax this if needed

### Why adapter layer?
- Enables gradual migration without breaking existing simulations
- Existing experiments continue using Genome
- New experiments can opt into GenomeV2
- Full migration only if Phase 4 validation succeeds

## What This Unblocks

**Immediate** (Phase 2):
- Promote habitat/trophic/defense from derived scalars to mutable loci
- Add sensor_range, metabolic_efficiency_primary/secondary as new traits
- Enable per-agent trait evolution independent of three-axis conflation

**Medium-term** (Phase 3):
- Complexity ratchet metrics (loci count, phenotype diversity)
- Trajectory tracking of genome size over evolutionary time
- Detect unbounded complexity increase without fitness advantage

**Long-term** (Phase 4):
- Validation: does GenomeV2 enable positive vs-null deltas?
- Falsification: if null persists, representational capacity insufficient alone
- Decision: continue expansion or pivot to behavioral/environmental combinations

## Next Session Options

### Option 1: Continue Phase 2 (highest leverage)
- Wire GenomeV2 into reproduction and physiology
- Remove derived computation (habitat/trophic/defense)
- Add new trait loci (sensor_range, metabolic_efficiency_*)
- Run smoke test confirming behavioral equivalence
- **Risk**: Medium (touches many files)
- **Reward**: High (unlocks actual cumulative innovation)

### Option 2: Jump to Phase 3 (validation-first)
- Add complexity metrics without full integration
- Run canonical baseline with GenomeV2 via adapter
- Check for emergent differentiation vs fixed genome
- **Risk**: Low (observability only)
- **Reward**: Medium (early validation signal)

### Option 3: Combine expansions
- GenomeV2 + behavioral control (internal state, policies)
- GenomeV2 + environmental complexity (niche construction)
- **Risk**: High (large scope)
- **Reward**: Potentially higher if representational capacity alone insufficient

## Recommendation
**Continue Phase 2.** The infrastructure is solid, tests pass, and the decision memo analysis was thorough. Representational Capacity is the foundation for other expansions—invest one more session wiring it into physiology before validating. If Phase 2 shows thrashing or ambiguity, pause and jump to Phase 3 validation.

## Evidence-Based Reflection

### What worked
- Following decision memo recommendation (explicit action path)
- Small, tested increments (three commits, each tested)
- Adapter pattern (enables gradual migration)
- Comprehensive documentation (roadmap prevents future sessions from re-planning)

### What to watch
- Phase 2 scope creep (touching many files can cascade)
- Validation timing (too early wastes Phase 2 work, too late wastes time on wrong path)
- Combination necessity (if GenomeV2 shows nullity, need behavioral/environmental pairing)

### Falsification criteria (Phase 4)
If canonical baseline with GenomeV2 shows:
- Same nullity as fixed genome → representational capacity insufficient alone
- No complexity ratchet signal → mechanism doesn't enable cumulative innovation
- No phenotype diversity increase → trait space isn't expanding

Then: pivot to combination expansions (GenomeV2 + behavioral OR GenomeV2 + environmental).

## Commits
1. `2a6ee11` feat: add GenomeV2 extensible trait architecture
2. `cc72116` feat: add GenomeV2 adapter layer for simulation integration
3. `b23ff55` docs: document GenomeV2 Phase 1 completion and roadmap

## Session Outcome
✓ Phase 1 complete
✓ 264 tests passing (no regressions)
✓ Clear roadmap for Phase 2-4
✓ Falsification criteria defined
✓ Decision memo recommendation executed
